Entero Therapeutics股票讨论区

盘后有些注意点。以下是需要关注的水平。
更大的图片： tradingview.com...
$Entero Therapeutics (ENTO.US)$ 

$Venus Concept (VERO.US)$ $Direct Digital (DRCT.US)$ $Entero Therapeutics (ENTO.US)$ $Knightscope (KSCP.US)$ $Monopar Therapeutics (MNPR.US)$ $Alternus Clean Energy (ALCE.US)$ $Nuwellis (NUWE.US)$ $ZenaTech (ZENA.US)$ $NewGenIvf (NIVF.US)$ $富原集团 (TWG.US)$
📊⚡️📊

$Entero Therapeutics (ENTO.US)$
小心炒作，赚钱后及时离场。

$Entero Therapeutics (ENTO.US)$ 持有！

$uniQure NV (QURE.US)$ $Apogee Enterprises (APOG.US)$ $Capricor Therapeutics (CAPR.US)$ $noco-noco (NCNC.US)$ $向上融科 (TIGR.US)$ $JBDI Holdings (JBDI.US)$ $Snail (SNAL.US)$ $Cue Biopharma (CUE.US)$ $Entero Therapeutics (ENTO.US)$ $Power REIT (PW.US)$ $福特汽车 (F.US)$ $Beneficient (BENF.US)$ $Phoenix Motor (PEV.US)$ $香颂国际 (CHSN.US)$
📊⚡️📊

$Entero Therapeutics (ENTO.US)$
Entero Therapeutics Signs Letter of Intent to License and Commercialize Remote Patient and Machine Vision Clinical Trial Management Platform from Data Vault Holdings
BOCA RATON, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ:ENTO), ("Entero Therapeutics" or the "Company"), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced...

$Entero Therapeutics (ENTO.US)$ 发生了什么